Pfizer

•

Kênh • 7 chương trình

Khoa học đời sống

Khoa học đời sống

Hằng tuần
Khoa học đời sống

Khoa học đời sống

15/12/2025
Y học

Y học

17/09/2025
Khoa học đời sống

Khoa học đời sống

21/11/2023
Khoa học đời sống

Khoa học đời sống

Hằng tháng
Khoa học viễn tưởng

Khoa học viễn tưởng

Series
Y học

Y học

Hằng tuần

2 NGÀY TRƯỚC

The Alarming Rise of Early-Onset Cancers

Why are more young adults getting cancer? That's one of the most pressing questions facing the scientific community today. Traditionally thought of as a disease that affects aging populations, recent data shows that cancer diagnoses for people under the age of 50 are increasing. To tackle this problem, it’ll take a global effort. In this episode you’ll hear from patients, oncologists, researchers and health care providers who are coming together to address this issue head on. Featured guests: – Dr. Marshall Anthony Jr., social scientist and colorectal cancer patient – Dr. Johanna Bendell, Chief Development Officer of Oncology, Pfizer – Dr. Yin Cao, molecular cancer epidemiologist; Cao Lab leader, Washington University – Dr. Beatrice Dionigi, colorectal cancer surgeon; founder & co‑director, Early Onset Colon and Rectal Cancer Project, Columbia Research Cancer Center – Dr. Susan Zhang, Global Development Lead, Pfizer Oncology Dive into the episode here: 00:00 – A patient story reveals an alarming new trend 6:30 – The data behind the rise of early-onset cancer 10:39 – The global search for a cause 14:13 – The unique challenges facing young people with cancer 20:28 – Screening guidelines and what to expect from a colonoscopy 25:17 – The importance of early detection 27:59 – The conclusion of Marshall's cancer journey 30:23 – What's next, and closing thoughts Check out our YouTube channel (@Pfizer) to watch the full interview with Raven & Dr. Marshall Anthony Jr. on his colorectal cancer journey. Season 6 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter. It’s produced by Acast Creative Studios. Hosts in this podcast series were compensated for their time. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

2 ngày trước

•

34 phút
18/11/2025

Part 4 — From Discovery to Delivery: How Scientists Are Revolutionizing Cancer Treatment

In drug discovery and development, every part of the process matters. Scientists learn from every experiment and every observation. In fact, some of the most cutting-edge advancements in medicine are being dreamed up from findings uncovered in the past. In this episode, co-hosts Dr. Raven Baxter and Dr. Ronald Gamble dive deep into antibody drug conjugates, a groundbreaking modality that uses targeted antibody engineering to deliver potent chemotherapy directly to cancer-causing cells. They explore the complex ADC creation process and learn how ADCs are changing the standard of care for bladder cancer, from someone with a personal relationship to the disease. Featured Guests: – Renee Barron-Gores, Caregiver – Phoenix Ho, Vice President, Oncology Early Clinical Development, Pfizer – Sharsti Sandall, Executive Director, ADC Biology, Oncology Research Unit, Pfizer Dive into the episode here: 1:16 - Old ideas yield new discoveries 3:01 - How do antibody drug conjugates work? 5:07 - The origins of ADCs 8:36 - ADCs allow for more targeted cancer treatment 10:44 - How are ADCs structured? 14:16 - How do scientists find the best ADC combinations? 18:27 - Developing oncology drugs 22:02 - ADCs and bladder cancer 24:28 - A caregiver’s perspective on cancer treatment 38:12 - Science Will Win Season 5 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter and Dr. Ronald Gamble. It’s produced by Acast Creative Studios. Check out our social media platforms to take a deeper look into the labs and stories we discuss during the episodes: Instagram (@pfizerinc), TikTok (@pfizer) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

18/11/2025

•

41 phút
28/10/2025

Part 1 — The Case of the Missing Vaccine

Medical advancements don’t just spring up—they happen by building on decades of previous discoveries. Today, one of these advancements might be on the verge of another breakthrough. But what had to happen first for it to exist? In this episode, co-hosts Dr. Raven Baxter and Dr. Ronald Gamble explore how a vaccine candidate for a deadly, once-mysterious bacterial disease came to be. The story takes them from one doctor’s groundbreaking connection in the 70s, all the way to a real lab where vaccines are being developed today. Featured Guests: – Carol Baker, Pediatric Infectious Disease Specialist – Isis Kanevsky, Senior Director, Vaccines, Pfizer – Ksenia Krylova, Senior Director, Vaccines, Pfizer Dive into the episode here: 02:54 - Getting into the problem 05:11 - The basics of immunity and vaccine science 09:32 - What is a conjugate vaccine? 14:44 - Group B Strep: A case study 22:23 - Talking to a GBS pioneer 31:40 - A trip to the lab 43:08 - What's next, and closing thoughts Season 5 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter and Dr. Ronald Gamble. It’s produced by Acast Creative Studios. Check out our social media platforms to take a deeper look into the labs and stories we discuss during the episodes: Instagram (@pfizerinc), TikTok (@pfizer) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

28/10/2025

•

49 phút
ĐOẠN GIỚI THIỆU PHIM CỦA PHẦN 6

Let’s Talk About Cancer — Season 6 Coming Soon

Science Will Win is back for a new season! Dr. Raven Baxter, a molecular biologist also known as Raven the Science Maven, returns as our host to dive into the latest in oncology: The latest challenges, the latest research, the latest treatment approaches, and the latest sources of progress and optimism keeping researchers going. You’ll hear from leading doctors, cutting-edge scientists, insightful historians, and inspiring patients sharing powerful stories of resilience. Plus, for the first time, you can find full length video discussions led by Raven on Pfizer’s YouTube channel. Season 6 of Science Will Win is coming soon—subscribe to stay tuned in! Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Trailer M6

•

10 phút
04/11/2025

Part 2 — The Mighty, Multifaceted Molecule

The next frontier of medicine is focused on highly targeted drug therapies that could expand the possibilities of individualized patient care. Today, scientists are working on a particular type of molecule that could harness multiple capabilities and treat inflammatory and autoimmune diseases in ways never done before. In this episode, co-hosts Dr. Raven Baxter and Dr. Ronald Gamble explore how the latest advancements in antibody engineering led to multispecific antibodies—powerhouse molecules that can do the jobs of multiple drugs in one. They learn all about what it takes to assemble these antibodies and the impact they could make on patients—with a patient. Featured Guests: – Emma Guttman, Chair of the Department of Dermatology, Icahn School of Medicine at Mount Sinai – Amanda Lopez, Patient, Texas Ambassador for the National Eczema Association – Laird Bloom, Senior Director of Biomedicine Design, Pfizer – Thomas Wynn, Vice President of Discovery, Inflammation & Immunology, Pfizer Dive into the episode here: 1:12 - A metaphor for multispecific antibodies 4:08 - How do multispecific antibodies work? 10:39 - The history behind multispecific antibodies 16:29 - How are multispecific antibody drugs are made? 22:58 - An eczema expert on the potential of multispecific antibodies 29:30 - Amanda Lopez's eczema story 40:14 - What's next, and closing thoughts Season 5 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter and Dr. Ronald Gamble. It’s produced by Acast Creative Studios. Check out our social media platforms to take a deeper look into the labs and stories we discuss during the episodes: Instagram (@pfizerinc), TikTok (@pfizer) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

04/11/2025

•

42 phút
11/11/2025

Part 3 — Getting Attached to Molecular Glues

Protein-protein interactions facilitate numerous bodily processes – everything from the basics of how our muscles contract to the more complex ways cancer can spread through the body. So, what if there was a way to alter some of these interactions? Or even create new ones? In this episode, we’re diving into the fascinating field of molecular glues, a revolutionary modality on the precipice of changing the treatment landscape for certain cancers and potentially other diseases and conditions. Featured Guests: – Joyann Donaldson, Principal Scientist, Synthesis Group Lead, Pfizer – Jennifer LaFontaine, Head of Oncology Medicinal Chemistry, Pfizer – Neal Sach, Research Fellow, Pfizer – Jillian Spangler, Associate Research Fellow, Pfizer Dive into the episode here: 0:50 - A metaphor to explain molecular glues 2:36 - How do molecular glues work in the body? 5:57 - A new frontier for cancer treatment 13:05 - The history behind molecular glues 16:59 - How do scientists design molecular glues? 19:05 - A visit to Pfizer’s La Jolla labs 32:42 - How can molecular glues change the patient experience? 36:42 - Molecular glues beyond cancer treatment Season 5 of Science Will Win is created by Pfizer and hosted by Dr. Raven Baxter and Dr. Ronald Gamble. It’s produced by Acast Creative Studios. Check out our social media platforms to take a deeper look into the labs and stories we discuss during the episodes: Instagram (@pfizerinc), TikTok (@pfizer) Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

11/11/2025

•

40 phút
27/10/2022

Part 1: Breast Cancer: The Science, The Challenges, The Solutions

Oncologists have more innovative methods for treating breast cancer than ever before. In part one of this two-part series, Adam Rutherford and guests explore the hurdles and successes researchers face as they work to develop new, targeted therapies for breast cancer. Featured Guests: Martha Carlson, Breast Cancer Advocate & WriterDr. Edith Mitchell, Medical Oncologist, Thomas Jefferson UniversityJeff Settleman, Chief Scientific Officer, Pfizer Oncology Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

27/10/2022

•

31 phút
26/06/2024

menopause: unmuted: Karen & Mark: On good communication through marriage and menopause

The debut episode of this season features couple Karen and Mark, who got married in the midst of Karen’s menopause journey. Tender, uplifting, and honest: their story captures how good communication through the menopause experience can help strengthen a relationship. Karen has used her own experiences to help other women, and Mark adds an invaluable perspective, as the first male voice of the podcast. Their story is about getting second chances in midlife and exemplifies how important patience and good communication are for supporting a partner through menopause. Useful Links: You can learn more about brain fog and how to help have a calm menopause in our previous bonus episode A Calm Menopause with Dr. Pauline MakiAre you interested in sharing your menopause story on the podcast? You can pass your contact details to the production team for further consideration by filling out this form.Disclaimer: menopause: unmuted is designed to raise awareness, encourage communication, and share information. It is not designed to provide medical advice or promote or recommend any treatment option. _______________ Women's Health is your destination for compelling, stand-out series that touch on all aspects of women's health. While each series may focus on a different topic, they're united in their commitment to candid conversations that destigmatize women's health issues and highlight real life people. Learn more about each series featured below: menopause: unmuted is honest, hopeful, life-affirming, and features real women talking candidly about their menopause, and its impact on relationships, friends, family, and work. Each episode shares deeply personal accounts of the different emotional and physical symptoms experienced. Our host, leading women’s health expert Dr. Mary Jane Minkin, provides an expert perspective, busting myths and offering evidence-based information. These podcasts are not designed to provide medical advice or promote or recommend any treatment option. This podcast feed is powered by Pfizer. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

26/06/2024

•

30 phút
15/11/2023

Part 1 – The Battle Against Antibiotic Resistance

Medicine’s struggle with antibiotic resistant bacteria is reaching a crisis point. In part one of this four-part series, host Jeremiah Owyang and expert guests delve into the world of antibiotics, exploring their history, the rise of antibiotic resistance, and the story of a patient whose life was forever changed by antibiotic-resistant bacteria. They break down the critical issues at stake and discuss the multifaceted solutions needed to combat this pressing crisis – including artificial intelligence. Featured Guests: Adrian Egli, Director, Institute of Medical Microbiology, University of ZurichJay Purdy, Vice President and Therapeutic Area Lead, Global Medical Affairs, Pfizer Antibacterial and Antifungal ProgramsMary Lynne Van Poelgeest-Pomfret, President, World Federation of Incontinence and Pelvic Problems Season 3 of Science Will Win is created by Pfizer and hosted by Jeremiah Owyang, entrepreneur, investor, and tech industry analyst. It’s produced by Wonder Media Network. Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

15/11/2023

•

28 phút
27/10/2022

Part 2: Clinical Trials: Bringing Research to Life

In part two of this series, Adam Rutherford and guests break down the next step in how potential breast cancer treatments move forward from the lab. What role do clinical trials play in the development of potential treatments? How are clinical trials developed? How can patients access clinical trials? And how are researchers and advocacy groups working to break down barriers in access to clinical trials? Featured Guests: Laurie, Breast Cancer Clinical Trial ParticipantDr. Edith Mitchell, Medical Oncologist, Thomas Jefferson UniversityJulia Perkins Smith, Global Clinical Lead, PfizerJamil Rivers, CEO, Chrysalis InitiativeAdditional Resources: pfizerclinicaltrials.com/oncologypfizerclinicaltrials.compfizerestudiosclinicos.com Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

27/10/2022

•

29 phút

Go behind the breakthroughs and explore the stories of the work we do at Pfizer around the globe, in conversations with the scientists and leaders who make it happen. Listen to recent episodes and follow along.

Trang Web

Pfizer

Top Chương Trình

Top Tập Podcast

Giới Thiệu